English
Deutsch
Español
Français
Polski
Português
Română
Русский
繁體中文

Stem Cell Treatment for Motor Neuron Diseases

A combination of stem cells and extensive therapies giving the patient real chances of improvement

What Makes our Treatment for Motor Neuron Diseases (MND) Effective?

Since 2005, we have been developing comprehensive stem cell treatment protocols for Motor Neuron Diseases (MND) such as Primary Lateral Sclerosis (PLS) and Amyotrophic Lateral Sclerosis (ALS) to overcome the limitations of conventional therapies. In our protocols, stem cells are combined with specialized therapies for motor neuron diseases that not only focus on helping the patient to cope with their symptoms, but also treat the direct cause of the loss of function by promoting healing of the damaged nerves and promote muscle growth. We believe that our comprehensive treatment approach for MND gives our patients the best chances of improvements, allowing for a better quality of life.

How can mesenchymal stem cells help patients with MND?

The mesenchymal stem cells used for treatment have the ability to differentiate into a variety of cell types and can migrate to damaged tissues to promote repair and regeneration. They also have immunomodulatory properties, which can help reduce inflammation in the central nervous system, a hallmark of many neurodegenerative diseases. Several preclinical and clinical studies have shown promising results using mesenchymal stem cells to treat neurodegenerative diseases.

Potential improvements after stem cell treatment for Motor Neuron Disease

The purpose of the treatment for MNDs is to promote repair of the neurological damage and regulate the immune system. Various kinds of improvement are possible after our treatment and our past patients have experienced the following*:

  • Improved motor function
  • Improved balance
  • Better coordination
  • Decreased fatigue
  • Increased muscle tone and strength
  • Lowered tremor occurrence
  • Better speech and swallowing
  • Slowed down general disease progression

*It is important to remember that as for any medical treatment, improvements cannot be guaranteed. Please contact us for more information regarding the possible improvements for a particular case. Also remember that stem cells are no cure for the underlying neurodegenerative disease and potential improvements will only be temporary.

Our Treatment Program in Details

Beike is unlike any other stem cell treatment provider in the world, the reason? Since 2005, we have been developing and optimizing our stem cell treatment protocols with the concept that only a very comprehensive solution can allow our patients to truly benefit from stem cells. We believe that stimulation through various therapies is necessary to enhance stem cell regenerative response, therefore our protocols include daily therapies to support the stem cells. Finally, we provide a wide variety and large quantities of stem cells in order to adapt to each patient specific condition and deliver maximized regenerative potential.

Our stem cell transplantation program for motor neuron diseases (e.g. PLS, ALS) consist in 3 to 8 simple and minimally invasive injections of umbilical cord derived stem cells. The stem cells are transplanted using two separate methods: by intravenous way using a standard IV drip system, and through intrathecal injection performed after lumbar puncture. These two delivery methods allow for increased efficacy while ensuring safety and minimum inconvenience for the patient. Read more about each procedure below:

  • 10 to 23 Days Stay
  • IV & Intrathecal Injections
  • UCBSC / UCMSC Cells
  • Daily Therapy Program
  • 120-280 Million Cells
  • Nutrition Program

Patient Experience Stories

Find out more about patients previously treated with Beike stem cell protocols. The families participating in these blog posts talk about their stories and present their own view of the treatment, including thoughts regarding the daily therapies, the stem cell injection themselves as well as improvement noticed during and after treatment.

PLS Patient Receives 3rd Stem Cell Therapy

Since being diagnosed with primary lateral sclerosis (PLS) in February of 2016, Sylvie has taken three trips to Thailand to receive stem cell treatment, finishing her most recent treatment in October of 2018. Before receiving stem cell therapy for PLS, her symptoms included spasticity in her arms and legs, and she …

Update on Mia Ruthey (PLS) After Returning Home From Stem Cell Treatment

Primary Lateral Sclerosis (PLS) In June we reported about a Primary Lateral Sclerosis (PLS) patient named Mia. PLS is a degenerative condition, and as such Mia needs to get regular treatment to maintain a healthy quality of life and keep her condition from progressing. We captured her progress and journey …

Mia and another successful PLS treatment

PLS Stem cell treatment Mia, a patient who recently returned home had nothing but gratitude and even more results to share with us. Mia has been treated many times with Beike and BBH, and as such has been able to achieve a much higher quality of life than her condition …

Stem Cell Quality and Quantity Ensured

Packaging for Beike Biotechnology Stem Cell products

Different types of stem cells for different needs

Beike provides stem cells from two separate sources: umbilical cord blood and umbilical cord tissue. Umbilical cord related samples are donated by healthy mothers after normal births and are sent to Beike Biotech’s laboratories for processing.

After reviewing the patient’s full medical information, our doctors will recommend which source of stem cells should be used for treatment. Our treatment protocols may include one or multiple types of stem cells in combination depending on each patient’s specific condition.

Highest International Stem Cell Processing Standards

Beike Biotechnology is processing its own adult stem cells in its internationally accredited laboratories. The company has full control over the processing and quality control of all stem cell products, ensuring perfect safety and highest quality.

Stammzellenbehandlungen Doktor

Patient Videos

Below are video interviews recorded during treatment with Beike stem cells. The families showcased in these videos talk about their personal stories and their experience of the treatment including the improvement noticed.

The improvements mentioned in these videos are typical, however it does not guarantee that all patients may have the same improvements.

Why Choose Beike for a Stem Cell Treatment?

Experience: With more than a decade of practice, you are ensured to be advised and treated by competent professionals.

Safety: Accredited by the American Association of Blood Banks (AABB) and following highest international standards, our stem cell processing methods and laboratories ensure that you receive the best stem cell quality available.

Diversity: Multiple types of stem cells having different capabilities are available to adapt to each patient’s specific condition. We do not use the same type of stem cells for all patients.

Extensiveness: A complete supportive therapy program is provided daily to stimulate patient’s freshly transplanted stem cells. The best improvement can only be obtain by supporting your stem cells.

Support: A full follow-up program is provided after the treatment and you will be asked to take part in it at 1, 3, 6 and 12 months after treatment. Access to our team after the treatment is very important as you may receive further advice to maximize improvements.

Beike-Biotechnology head office building located in Shenzhen China

Founded in July 2005, Shenzhen Beike Biotechnology is a national high-tech enterprise specialized in clinical transformation and technical service of biological treatment technology of strategic emerging industries.

Get more information now